AJP - Heart Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 286: H1978-H1984, 2004. First published December 23, 2003; doi:10.1152/ajpheart.00414.2003
0363-6135/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/5/H1978    most recent
00414.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (27)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parenti, A.
Right arrow Articles by Ledda, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parenti, A.
Right arrow Articles by Ledda, F.

Endogenous VEGF-A is responsible for mitogenic effects of MCP-1 on vascular smooth muscle cells

Astrid Parenti, Lydia Bellik, Laura Brogelli, Sandra Filippi, and Fabrizio Ledda

Laboratory of Vascular Pharmacology, Department of Preclinical and Clinical Pharmacology, University of Florence, 50139 Florence, Italy

Submitted 5 May 2003 ; accepted in final form 16 December 2003

Vessel wall remodeling is a complex phenomenon in which the loss of differentiation of vascular smooth muscle cells (VSMCs) occurs. We investigated the role of rat macrophage chemoattractant protein (MCP)-1 on rat VSMC proliferation and migration to identify the mechanism(s) involved in this kind of activity. Exposure to very low concentrations (1–100 pg/ml) of rat MCP-1 induced a significant proliferation of cultured rat VSMCs assessed as cell duplication by the counting of total cells after exposure to test substances. MCP-1 stimulated VSMC proliferation and migration in a two-dimensional lateral sheet migration of adherent cells in culture. Endogenous vascular endothelial growth factor-A (VEGF-A) was responsible for the mitogenic activity of MCP-1, because neutralizing anti-VEGF-A antibody inhibited cell proliferation in response to MCP-1. On the contrary, neutralizing anti-fibroblast growth factor-2 and anti-platelet-derived growth factor-bb antibodies did not affect VSMC proliferation induced by MCP-1. RT-PCR and Western blot analyses showed an increased expression of either mRNA or VEGF-A protein after MCP-1 activation (10–100 pg/ml), whereas no fms-like tyrosine kinase (Flt)-1 receptor upregulation was observed. Because we have previously demonstrated that hypoxia (3% O2) can enhance VSMC proliferation induced by VEGF-A through Flt-1 receptor upregulation, the effects of hypoxia on the response of VSMCs to MCP-1 were investigated. Severe hypoxia (3% O2) potentiated the growth-promoting effect of MCP-1, which was able to significantly induce cell proliferation even at a concentration as low as 0.1 pg/ml. These findings demonstrate that low concentrations of rat MCP-1 can directly promote rat VSMC proliferation and migration through the autocrine production of VEGF-A.

monocyte chemotactic protein-1; endogenous vascular endothelial growth factor-A; remodeling; autocrine proliferation; chemokine



Address for reprint requests and other correspondence: F. Ledda, Dept. of Preclinical and Clinical Pharmacology, Univ. of Florence, Viale G. Pieraccini, 6, 50139 Florence, Italy (E-mail: ledda{at}pharm.unifi.it).




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
G. Grassia, M. Maddaluno, A. Guglielmotti, G. Mangano, G. Biondi, P. Maffia, and A. Ialenti
The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice
Cardiovasc Res, December 1, 2009; 84(3): 485 - 493.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Simons
VEGF and Restenosis: The Rest of the Story
Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 439 - 440.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J.-i. Koga, T. Matoba, K. Egashira, M. Kubo, M. Miyagawa, E. Iwata, K. Sueishi, M. Shibuya, and K. Sunagawa
Soluble Flt-1 Gene Transfer Ameliorates Neointima Formation After Wire Injury in flt-1 Tyrosine Kinase-Deficient Mice
Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 458 - 464.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Chen, A. Frister, S. Wang, A. Ludwig, H. Behr, S. Pippig, B. Li, A. Simm, B. Hofmann, C. Pilowski, et al.
Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H987 - H996.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Li, R. Loberg, J. Liao, C. Ying, L. A. Snyder, K. J. Pienta, and L. K. McCauley
A Destructive Cascade Mediated by CCL2 Facilitates Prostate Cancer Growth in Bone
Cancer Res., February 15, 2009; 69(4): 1685 - 1692.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. A. Lang, P. Schachtschneider, C. Moser, A. Mori, C. Hackl, A. Gaumann, D. Batt, H. J. Schlitt, E. K. Geissler, and O. Stoeltzing
Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes
Mol. Cancer Ther., November 1, 2008; 7(11): 3509 - 3518.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J. Haurani and P. J. Pagano
Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: Bellwether for vascular disease?
Cardiovasc Res, September 1, 2007; 75(4): 679 - 689.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Koide, M. Okazaki, M. Tamura, K. Ozumi, H. Takatsu, F. Kamezaki, A. Tanimoto, H. Tasaki, Y. Sasaguri, Y. Nakashima, et al.
PTEN reduces cuff-induced neointima formation and proinflammatory cytokines
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2824 - H2831.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. Nakagawa, W. Sato, O. Glushakova, M. Heinig, T. Clarke, M. Campbell-Thompson, Y. Yuzawa, M. A. Atkinson, R. J. Johnson, and B. Croker
Diabetic Endothelial Nitric Oxide Synthase Knockout Mice Develop Advanced Diabetic Nephropathy
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 539 - 550.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Sakao, L. Taraseviciene-Stewart, K. Wood, C. D. Cool, and N. F. Voelkel
Apoptosis of pulmonary microvascular endothelial cells stimulates vascular smooth muscle cell growth
Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L362 - L368.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Chon, M. C. Verhaar, H. A. Koomans, J. A. Joles, and B. Braam
Role of Circulating Karyocytes in the Initiation and Progression of Atherosclerosis
Hypertension, May 1, 2006; 47(5): 803 - 810.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. Nakagawa, W. Sato, Y. Y. Sautin, O. Glushakova, B. Croker, M. A. Atkinson, C. C. Tisher, and R. J. Johnson
Uncoupling of Vascular Endothelial Growth Factor with Nitric Oxide as a Mechanism for Diabetic Vasculopathy
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 736 - 745.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. I. Rotmans, J. M.M. Heyligers, H. J.M. Verhagen, E. Velema, M. M. Nagtegaal, D. P.V. de Kleijn, F. G. de Groot, E. S.G. Stroes, and G. Pasterkamp
In Vivo Cell Seeding With Anti-CD34 Antibodies Successfully Accelerates Endothelialization but Stimulates Intimal Hyperplasia in Porcine Arteriovenous Expanded Polytetrafluoroethylene Grafts
Circulation, July 5, 2005; 112(1): 12 - 18.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.